Ayala Pharmaceuticals Inc (ADXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
10-2019 | 07-2019 | 04-2019 | 01-2019 | 10-2018 | |
Sales | 0 | 6 | 1,188 | 19,689 | 0 |
Gross Profit | N/A | 6 | 1,188 | 19,689 | N/A |
Operating Expenses | 0 | 10,136 | 9,061 | 9,373 | 0 |
Operating Income | N/A | -10,130 | -7,873 | 10,316 | N/A |
Other Income | 0 | 272 | -1,510 | 2,551 | 0 |
Pre-tax Income | 0 | -9,858 | -9,383 | 12,867 | 0 |
Income Tax | N/A | N/A | N/A | 50 | N/A |
Net Income Continuous | N/A | -9,858 | -9,383 | 12,817 | N/A |
Net Income | $N/A | $-9,858 | $-9,383 | $12,817 | $N/A |
EPS Basic Total Ops | N/A | -80.00 | -127.20 | 220.80 | N/A |
EPS Basic Continuous Ops | N/A | -79.90 | -127.23 | 220.84 | N/A |
EPS Diluted Total Ops | N/A | -80.00 | -127.20 | 220.80 | N/A |
EPS Diluted Continuous Ops | N/A | -79.90 | -127.23 | 220.84 | N/A |
EBITDA(a) | $N/A | $-9,756 | $-7,490 | $10,697 | $N/A |